eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
10.45
+0.44 (4.40%)
At close: Apr 8, 2026, 4:00 PM EDT
10.31
-0.14 (-1.34%)
After-hours: Apr 8, 2026, 4:00 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $88.61 million as of April 8, 2026. Its market cap has decreased by -50.03% in one year.
Market Cap
88.61M
Enterprise Value
85.62M
1-Year Change
-50.03%
Ranking
Category
Stock Price
$10.45
Market Cap Chart
Since November 13, 2024, eXoZymes's market cap has increased from $70.30M to $88.61M, an increase of 26.04%. That is a compound annual growth rate of 18.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 84.87M | -7.16% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 78.57M |
| MAIA Biotechnology | 78.27M |
| Fortress Biotech | 77.91M |
| Cognition Therapeutics | 74.85M |
| NRx Pharmaceuticals | 74.33M |
| Adicet Bio | 74.17M |
| Coeptis Therapeutics Holdings | 72.75M |
| Fractyl Health | 72.50M |